Correlation Between AnterogenCoLtd and Korean Drug

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AnterogenCoLtd and Korean Drug at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AnterogenCoLtd and Korean Drug into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AnterogenCoLtd and Korean Drug Co, you can compare the effects of market volatilities on AnterogenCoLtd and Korean Drug and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AnterogenCoLtd with a short position of Korean Drug. Check out your portfolio center. Please also check ongoing floating volatility patterns of AnterogenCoLtd and Korean Drug.

Diversification Opportunities for AnterogenCoLtd and Korean Drug

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between AnterogenCoLtd and Korean is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding AnterogenCoLtd and Korean Drug Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Korean Drug and AnterogenCoLtd is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AnterogenCoLtd are associated (or correlated) with Korean Drug. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Korean Drug has no effect on the direction of AnterogenCoLtd i.e., AnterogenCoLtd and Korean Drug go up and down completely randomly.

Pair Corralation between AnterogenCoLtd and Korean Drug

Assuming the 90 days trading horizon AnterogenCoLtd is expected to generate 1.86 times more return on investment than Korean Drug. However, AnterogenCoLtd is 1.86 times more volatile than Korean Drug Co. It trades about 0.26 of its potential returns per unit of risk. Korean Drug Co is currently generating about 0.07 per unit of risk. If you would invest  1,915,000  in AnterogenCoLtd on November 4, 2024 and sell it today you would earn a total of  295,000  from holding AnterogenCoLtd or generate 15.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy94.44%
ValuesDaily Returns

AnterogenCoLtd  vs.  Korean Drug Co

 Performance 
       Timeline  
AnterogenCoLtd 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in AnterogenCoLtd are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, AnterogenCoLtd sustained solid returns over the last few months and may actually be approaching a breakup point.
Korean Drug 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Korean Drug Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Korean Drug is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

AnterogenCoLtd and Korean Drug Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AnterogenCoLtd and Korean Drug

The main advantage of trading using opposite AnterogenCoLtd and Korean Drug positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AnterogenCoLtd position performs unexpectedly, Korean Drug can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Korean Drug will offset losses from the drop in Korean Drug's long position.
The idea behind AnterogenCoLtd and Korean Drug Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites